In recent years, the psoriasis market is anticipated to proliferate during the forecast period. Despite the fact that healthcare is progressively migrating to value-based care for better patient outcomes and enhanced quality of life, the global rise in psoriasis prevalence is encouraging investments in treatment and management strategies. As a result, manufacturers in the psoriasis industry have shifted their focus to research and development in order to improve disease management, resulting in the creation of newer, more effective medications.
Frequently Asked Questions
The market is segmented based on Global Psoriasis Market Segmentation, By Types (Nail Psoriasis, Guttate Psoriasis, Psoriatic Arthritis, Others), Treatment (Medication, Phototherapy, Others), Diagnosis (Physical Examination, Skin Biopsy, Others), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Psoriasis Market size was valued at USD 31.68 USD Billion in 2024.
The Global Psoriasis Market is projected to grow at a CAGR of 9.2% during the forecast period of 2025 to 2032.
The major players operating in the market include ,Pfizer Inc. GlaxoSmithKline plc Novartis AG Mylan N.V. Teva Pharmaceutical Industries Ltd. Sanofi Boehringer Ingelheim International GmbH. AstraZeneca Johnson &, Johnson Private Limited Bayer AG Merck &, Co.Inc. F. Hoffmann-La Roche Ltd. Bristol-Myers Squibb Company Cadila Pharmaceuticals Eli Lilly and Company LEO Pharma A/S Cipla Inc. Aurobindo Pharma Lupin Sumitomo Corporation ,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
